# Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients

> **NCT03438773** · PHASE1 · UNKNOWN · sponsor: **California Institute of Renal Research** · enrollment: 50 (estimated)

## Conditions studied

- Kidney Transplant; Complications
- Kidney Transplant Failure and Rejection

## Interventions

- **DRUG:** Envarsus
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT03438773
- **Lead sponsor:** California Institute of Renal Research
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-11
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-02-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03438773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03438773, "Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03438773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*